U.S. flag

An official website of the United States government

NM_000070.3(CAPN3):c.1357dup (p.Thr453fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2A

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Aug 31, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002690317.5

Allele description [Variation Report for NM_000070.3(CAPN3):c.1357dup (p.Thr453fs)]

NM_000070.3(CAPN3):c.1357dup (p.Thr453fs)

Genes:
LOC130056921:ATAC-STARR-seq lymphoblastoid active region 9300 [Gene]
CAPN3:calpain 3 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
15q15.1
Genomic location:
Preferred name:
NM_000070.3(CAPN3):c.1357dup (p.Thr453fs)
HGVS:
  • NC_000015.10:g.42401643dup
  • NG_008660.1:g.58541dup
  • NM_000070.3:c.1357dupMANE SELECT
  • NM_024344.2:c.1357dup
  • NM_173087.2:c.1213dup
  • NM_212464.2:c.1096dup
  • NM_212467.2:c.*1050dup
  • NP_000061.1:p.Thr453fs
  • NP_077320.1:p.Thr453fs
  • NP_775110.1:p.Thr405fs
  • NP_997629.1:p.Thr366Asnfs
  • LRG_849t1:c.1357dup
  • LRG_849:g.58541dup
  • LRG_849p1:p.Thr453fs
  • NC_000015.9:g.42693840_42693841insA
  • NC_000015.9:g.42693841dup
Protein change:
T405fs
Molecular consequence:
  • NM_000070.3:c.1357dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_024344.2:c.1357dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_173087.2:c.1213dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_212464.2:c.1096dup - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Autosomal recessive limb-girdle muscular dystrophy type 2A (LGMDR1)
Synonyms:
Limb-girdle muscular dystrophy, type 2A; Limb-girdle muscular dystrophy type 2; Muscular dystrophy, pelvofemoral; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009675; MedGen: C1869123; Orphanet: 267; OMIM: 253600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002994941Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 28, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV004031062Intergen, Intergen Genetics and Rare Diseases Diagnosis Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 31, 2023)
biparentalclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedbiparentalyes1not providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness.

Töpf A, Johnson K, Bates A, Phillips L, Chao KR, England EM, Laricchia KM, Mullen T, Valkanas E, Xu L, Bertoli M, Blain A, Casasús AB, Duff J, Mroczek M, Specht S, Lek M, Ensini M, MacArthur DG; MYO-SEQ consortium., Straub V.

Genet Med. 2020 Sep;22(9):1478-1488. doi: 10.1038/s41436-020-0840-3. Epub 2020 Jun 11.

PubMed [citation]
PMID:
32528171
PMCID:
PMC7462745

Calpainopathy-a survey of mutations and polymorphisms.

Richard I, Roudaut C, Saenz A, Pogue R, Grimbergen JE, Anderson LV, Beley C, Cobo AM, de Diego C, Eymard B, Gallano P, Ginjaar HB, Lasa A, Pollitt C, Topaloglu H, Urtizberea JA, de Visser M, van der Kooi A, Bushby K, Bakker E, Lopez de Munain A, Fardeau M, et al.

Am J Hum Genet. 1999 Jun;64(6):1524-40.

PubMed [citation]
PMID:
10330340
PMCID:
PMC1377896
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV002994941.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This premature translational stop signal has been observed in individual(s) with CAPN3-related conditions (PMID: 32528171). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr453Asnfs*18) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Intergen, Intergen Genetics and Rare Diseases Diagnosis Center, SCV004031062.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
11not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1biparentalyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Feb 28, 2024